Selection of highly osteogenic and chondrogenic cells from bone marrow stromal cells in biocompatible polymer-coated plates

✍ Scribed by G. Liu; K. Iwata; T. Ogasawara; J. Watanabe; K. Fukazawa; K. Ishihara; Y. Asawa; Y. Fujihara; U.-L. Chung; T. Moro; Y. Takatori; T. Takato; K. Nakamura; H. Kawaguchi; K. Hoshi

• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 550 KB
• Volume: 9999A
• Category: Article
• ISSN: 1549-3296
• DOI: 10.1002/jbm.a.32460

✦ Synopsis

Abstract

To enrich the subpopulation that preserves self‐renewal and multipotentiality from conventionally prepared bone marrow stromal cells (MSCs), we attempted to use 2‐methacryloyloxyethyl phosphorylcholine (MPC) polymer‐coated plates that selected the MSCs with strong adhesion ability and evaluated the proliferation ability or osteogenic/chondrogenic potential of the MPC polymer‐selected MSCs. The number of MSCs that were attached to the MPC polymer‐coated plates decreased with an increase in the density of MPC unit (0–10%), whereas no significant difference in the proliferation ability was seen among these cells. The surface epitopes of CD29, CD44, CD105, and CD166, and not CD34 or CD45, were detectable in the cells of all MPC polymer‐coated plates, implying that they belong to the MSC category. In the osteogenic and chondrogenic induction, the MSCs selected by the 2–5% MPC unit composition showed higher expression levels of osteoblastic and chondrocytic markers (COL1A1/ALP, or COL2A1/COL10A1/Sox9) at passage 2, compared with those of 0–1% or even 10% MPC unit composition, while the enhanced effects continued by passage 5. The selection based on the adequate cell adhesiveness by the MPC polymer‐coated plates could improve the osteogenic and chondrogenic potential of MSCs, which would provide cell sources that can be used to treat the more severe and various bone/cartilage diseases. © 2009 Wiley Periodicals, Inc. J Biomed Mater Res 2010